Day: May 12, 2026

us corporate news

Madison Air Solutions Reports 33.8% Sales Growth and Completes $2.6B IPO in Q1 2026 Results

Minichart

May 12, 2026

Madison Air Solutions (NYSE: MAIR) Reports Robust Q1 2026 Re...

Continue Reading 0

us corporate news

Olema Oncology Announces Q1 2026 Financial Results and Upcoming Phase 3 Breast Cancer Trial Data

Minichart

May 12, 2026

Olema Oncology Q1 2026 Financial and Operating Results: Key ...

Continue Reading 0

us corporate news

Veritone Reports Q1 2026 Financial Results: Revenue Decline, Strategic AI Partnerships, and New Enterprise Contracts

Minichart

May 12, 2026

Veritone, Inc. Q1 2026 Financial Results - Investor Analysis...

Continue Reading 0

us corporate news

Acumen Pharmaceuticals Reports Q1 2026 Financial Results and Anticipates Phase 2 ALTITUDE-AD Data for Alzheimer’s Treatment

Minichart

May 12, 2026

Acumen Pharmaceuticals Reports Q1 2026 Results: Cash Infusio...

Continue Reading 0

us corporate news

Vestis Q2 2026 Earnings: Strong Cost Reductions Drive Record Adjusted EBITDA and Free Cash Flow Amid Flat Revenue

Minichart

May 12, 2026

Vestis Corp Q2 2026 Financial Results: Detailed Investor Upd...

Continue Reading 0

us corporate news

Alkermes Announces Positive Phase 3 Results for LUMRYZ in Idiopathic Hypersomnia, Plans FDA Submission by End of 2026

Minichart

May 12, 2026

Alkermes Announces Positive Phase 3 Results for LUMRYZ in Id...

Continue Reading 0

us corporate news

Sionna Therapeutics Reports Q1 2026 Financial Results and Completes Enrollment in PreciSION CF Phase 2a Trial

Minichart

May 12, 2026

Sionna Therapeutics Q1 2026 Financial Results: Investor Anal...

Continue Reading 0

us corporate news

SOLV Energy Reports 66% Revenue Growth and Raises 2026 EBITDA Guidance Following Strong Q1 Results and Roberson Waite Electric Acquisition

Minichart

May 12, 2026

SOLV Energy Q1 2026 Earnings: Full Investor Recap SOLV...

Continue Reading 0

us corporate news

Prelude Therapeutics Reports Q1 2026 Results, Advances Precision Oncology Pipeline and Extends Cash Runway to 2028

Minichart

May 12, 2026

Prelude Therapeutics Q1 2026 Financial Results and Corporate...

Continue Reading 0

us corporate news

Arvinas, Inc. Announces License Agreement for VEPPANU with Rigel – Key Details and Forward-Looking Statements

Minichart

May 12, 2026

Arvinas and Pfizer Ink \$85 Million Upfront Deal with Rigel ...

Continue Reading 0